‘AI becomes pro-artist’ according to Warner’s licensing agreement with Suno, but can it compete with the divine feminine? ‘AI becomes pro-artist’ according to Warner’s licensing agreement with Suno, but can it compete with the divine feminine? Reviewed by Georgia Jenkins on Saturday, November 29, 2025 Rating: 5

Saturday Sundries

Hunting for food discounts Another IP week has come to an end and IPKat readers might be too busy hunting for Black Week bargains, but here...
- Saturday, November 29, 2025
Saturday Sundries Saturday Sundries Reviewed by Eleonora Rosati on Saturday, November 29, 2025 Rating: 5
How the new EU Design Regulation can kill your infringement claim How the new EU Design Regulation can kill your infringement claim Reviewed by Marcel Pemsel on Friday, November 28, 2025 Rating: 5
Blending character traits in a cauldron may not be copyright infringement, says US Court of Appeals Blending character traits in a cauldron may not be copyright infringement, says US Court of Appeals Reviewed by Söğüt Atilla-Aydın on Friday, November 28, 2025 Rating: 5
‘It doesn’t pay to make predictions’ or perhaps it does for Perplexity AI? ‘It doesn’t pay to make predictions’ or perhaps it does for Perplexity AI? Reviewed by Georgia Jenkins on Thursday, November 27, 2025 Rating: 5
Beyond black and white: the EPO’s new rules for colour drawings Beyond black and white: the EPO’s new rules for colour drawings Reviewed by Simone Lorenzi on Thursday, November 27, 2025 Rating: 5
[Guest Post] Defensive trade marks in Australia - Gillette achieves acceptance for unused goods and services based on reputation [Guest Post] Defensive trade marks in Australia - Gillette achieves acceptance for unused goods and services based on reputation Reviewed by Jocelyn Bosse on Thursday, November 27, 2025 Rating: 5
[Guest post] Lost in (incidental) memorization: When the (case) law mistakes AI training for copying [Guest post] Lost in (incidental) memorization: When the (case) law mistakes AI training for copying Reviewed by Söğüt Atilla-Aydın on Wednesday, November 26, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Simone Lorenzi on Wednesday, November 26, 2025 Rating: 5
The breeder's exemption as the route to agreement in the EU debate on NGT plants The breeder's exemption as the route to agreement in the EU debate on NGT plants Reviewed by Jocelyn Bosse on Tuesday, November 25, 2025 Rating: 5
EPO pharma case law trends 2025: Clinical inventions EPO pharma case law trends 2025: Clinical inventions Reviewed by Dr Rose Hughes on Monday, November 24, 2025 Rating: 5
Powered by Blogger.